HCW Biologics is trading at $2.91, down 7.6% in after-hours as the stock pulls back from a sharp 22.09% regular-session jump.

  • The rally followed a recently announced $1.6 million private placement priced at $2.585 per unit.
  • The current move appears to be a normal post-rally consolidation after investors reacted positively to the financing news during the regular session, with no new company-specific headlines emerging after the close.